Versions - Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study

    Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study by Allen Cheng-Wei Li, Yang-Chi Lin, Jing-Yang Huang, Lung-Ching Chen, Su-Kiat Chua

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study.

    Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study. by Allen Cheng-Wei Li, Yang-Chi Lin, Jing-Yang Huang, Lung-Ching Chen, Su-Kiat Chua

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: